For making the first commercially available product derived from adult somatic cells. CDI brought its heart cells, which it calls Icell cardiomyocytes, to market last year. The groundbreaking technology gives researchers the power of pluripotent stem cells, speeding up the drug discovery process without the worry of a material shortage–a constant concern with embryonic stem cells, which are notoriously hyper-regulated. One customer, pharmaceutical giant Roche, uses the cells to screen drugs.FCS
collectionsNewslettersInnovation FestivalCurrent Issue
World Changing Ideas
New workplaces, new food sources, new medicine--even an entirely new economic system.
The major tech ecosystems that battle for our attention and dollars.
What’s next for hardware, software, and services.
The brave new world of automation, from AI to drones.
How our urban centers are building toward the future.
Most Creative People
See members of our Most Creative People in Business community: leaders who are shaping the future of business in creative ways.
An award-winning team of journalists, designers, and videographers who tell brand stories through Fast Company's distinctive lens.